Barr Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript

  • download
  • Print
  • Recommend
  • 0

2008-11-06 18:56:10.0

Tags: Goldman Sachs & Co., Call Transcript, Earnings, Barr Pharmaceuticals Inc., Federal Government, Sales Strategy, Government, Sales, Seeking Alpha, Goldman Sachs & Co., Call Transcript, Earnings, Barr Pharmaceuticals Inc., Federal Government, Sales Strategy, Government, Sales, Seeking Alpha

Question-and-Answer Session

[Operator Instructions]. Our first question comes from the line of Randall Stanicky from Goldman Sachs. Please go ahead.

Randall Stanicky - Goldman Sachs

Hey guys, thanks for the question. And I guess this is congratulation on what could be the last Barr call here. I guess just, could you update us Bruce on some of the near-term opportunities. I know Ortho TRI-CYCLEN LO, NASACORT AQ is still out there and then maybe you remind us how you're thinking about the opportunity on Adderall XR for '09?

Bruce L. Downey - Chairman and Chief Executive Officer

Well we continue to work through the agreements on TRI-CYCLEN LO, you have correctly noted that we have completed a trial of NASACORT and we have had on to acknowledge another forum that we have on going discussions about that case with the patent holder. We are hopeful of bringing those to a successful conclusion, if not it will in the hands of the court.

On the 2009, the Adderall XR we see as a very large opportunity and you know we have guaranteed six months of exclusivity and I think that product is well over billion dollars a year now in sales and I think its going to be an excellent product of 2009.

Randall Stanicky - Goldman Sachs

Any other near-term pipeline opportunities that we should be thinking about here?

William T. McKee - Executive Vice President and Chief Financial Officer

Well, as I alluded to in my prepared remarks... prepared is a strong word, in the remarks that I made, we do expect... had expected some new launches in the third quarter which we pushed off to the fourth quarter because there is some slowdowns at the FDA. We do expect some nice launches in the fourth quarter, but the significance will be lower for the year because of the shorter period of time.

Randall Stanicky - Goldman Sachs

Sure, okay I'll leave it at that. Thanks guys.

Operator

Thank you. Our next question is from the line of Ronny Gal from Bernstein, please go ahead.

Aaron (Ronny) Gal - Stanford C. Bernstein & Company

Good morning and thank you Bruce for all those wonderful conference call. We will certainly miss them.

Bruce L. Downey - Chairman and Chief Executive Officer

Well, some of the entertainment value will go down I guess.

Aaron (Ronny) Gal - Stanford C. Bernstein & Company

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here